Tamar Robotics Company

"Robot for Minimally Invasive Neurosurgery."

Tamar Robotics develops neurosurgical robotic technology that assists neurosurgeons in the operating room.
The company's technology is based on a five-year study conducted by Cofounder and Vice President of Research and Development Hadas Ziso at the medical robotics laboratory at the Technion.
The company has developed and deployed a novel protective patient hood that prevents the spread of COVID-19 and protects medical teams when applying non-invasive ventilation (NIV) therapy for patients with the disease, caused by the novel coronavirus. The product, called NIV Greenhouse, enables the use of non-invasive ventilation such as CPAP and BiPAP devices in COVID-19 treatment. These machines were previously deemed too risky for medical staff due to the potential for the spread of contagious disease from the patient’s breath. The product is a personal patient hood connected to a standard clean room filter. It combines air filtration around the patient’s head at levels that until now were only available in clean rooms used in the high-tech industry, together with a personal patient hood that shields the medical staff from the patient’s head. Initial units have already been installed and are in use at Carmel Medical Center, Ein Kerem Hospital in Jerusalem’s Hadassah Medical Center.

Combating Coronavirus Pandemic:
Tamar Robotics's solution helps address the Coronavirus Pandemic. Tamar Robotics, an Israeli developer of neurosurgical robotic technology solutions of the Tamar NIV group, developed and deployed a novel protective patient hood that the company says prevents the spread of COVID-19 and protects hospital workers who apply non-invasive ventilation (NIV) therapy to patients with the virus.
Technology: COVID Treatments
Industry: Preventive Tech
Headquarters: Israel
Founded Date: 2018
Employees Number: N/A
Funding Status: N/A

Register and Claim Ownership